Vir Biotechnology reports positive early hepatitis data as shares rise

Summary

Vir Biotechnology reported positive hepatitis results that Seeking Alpha describes as showing early signs of a possible cure. The next day, Seeking Alpha reported that Vir's shares rose on hepatitis D therapy data. This account rests on the two article headlines only, because the article summaries were empty. Trial design, figures and other details are not confirmed here.

Timeline

1. Seeking Alpha

   8 Nov 2026, 23:27 UTCSource ↗

   Seeking Alpha reports that Vir Biotechnology announced positive hepatitis results with early signs of a possible cure.

2. Seeking Alpha

   9 Nov 2026, 14:55 UTCSource ↗

   Seeking Alpha reports that Vir Biotechnology shares rose on hepatitis D therapy data.